David-Pfeuty T, Chakrani F, Ory K, Nouvian-Dooghe Y
Institut Curie-Biologie, Centre Universitaire, Orsay, France.
Cell Growth Differ. 1996 Sep;7(9):1211-25.
We have analyzed the regulation of subcellular compartmentation of mutant and wild-type (WT) p53 proteins as a function of the cell cycle using immunofluorescence microscopy and referring to different markers of position in the cell cycle in different human cells expressing either mutated (KHOS-240, A 431, and T47-D cells) or WT (WI 38 and MCF-7 cells) p53. The mutant p53 proteins present in the KHOS-240, A 431, and T47-D tumor-derived cell lines enter very rapidly in the nucleus in early postmitotic cells before the chromosomes have fully decondensed; they continue accumulating in this location without any obvious cytoplasmic retention throughout the cell cycle until prophase. Such behavior is similar to that observed for the WT p53 associating with SV40 large T antigen in human WI 38 cells transformed by SV40, but it is in contrast to the behavior of the WT p53 protein present in both the untransformed WI 38 and the tumor-derived MCF-7 cells. In these latter systems, the highest nuclear concentrations of the WT protein are always found in G1 cells that still fail to exhibit a high rate of nuclear cyclin A; past the G1-S transition, the nuclear level of WT p53 tends to decrease, possibly to the benefit of cytoplasmic expression, whereas that of cyclin A concomitantly increases, suggesting that the nuclear accumulation of WT p53 becomes restricted during the phase of DNA replication. As for Saos-2 cells stably transfected with the temperature-sensitive p53Ala-143 mutant, they become arrested before the G1-S transition with a heavy pool of nuclear p53 at 32.5 degrees C, the temperature at which the transcriptional activity of p53Ala-143 is restored. All these data are compatible with the presently acknowledged primary role for WT p53, which would be to brake transit through the G1-S border possibly by directly transactivating the p21cip1 protein.
我们利用免疫荧光显微镜技术,并参考不同人类细胞中细胞周期位置的不同标志物,分析了突变型和野生型(WT)p53蛋白的亚细胞区室化调控,这些细胞分别表达突变型(KHOS-240、A 431和T47-D细胞)或WT(WI 38和MCF-7细胞)p53。存在于KHOS-240、A 431和T47-D肿瘤衍生细胞系中的突变型p53蛋白,在有丝分裂后早期细胞中,在染色体完全解聚之前就非常迅速地进入细胞核;它们在整个细胞周期中持续在该位置积累,直到前期都没有明显的细胞质滞留。这种行为类似于在由SV40转化的人类WI 38细胞中与SV40大T抗原结合的WT p53所观察到的行为,但与未转化的WI 38和肿瘤衍生的MCF-7细胞中存在的WT p53蛋白的行为相反。在这些后一种系统中,总是在G1期细胞中发现WT蛋白的最高核浓度,这些细胞仍然没有显示出高核周期蛋白A的速率;在G1-S转换之后,WT p53的核水平趋于下降,可能有利于细胞质表达,而周期蛋白A的核水平则相应增加,这表明WT p53的核积累在DNA复制阶段受到限制。至于稳定转染了温度敏感型p53Ala-143突变体的Saos-2细胞,它们在32.5摄氏度时在G1-S转换之前停滞,此时有大量的核p53,在该温度下p53Ala-143的转录活性得以恢复。所有这些数据都与目前公认的WT p53的主要作用相一致,即可能通过直接反式激活p21cip1蛋白来阻止通过G1-S边界的过渡。